Impaired circulating myeloid CD1c+ dendritic cell function in human glioblastoma is restored by p38 inhibition - implications for the next generation of DC vaccines. (2019)
Attributed to:
Enhanced Dendritic Cell Immunology for Glioblastoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/2162402x.2019.1593803
PubMed Identifier: 31143512
Publication URI: http://europepmc.org/abstract/MED/31143512
Type: Journal Article/Review
Volume: 8
Parent Publication: Oncoimmunology
Issue: 7
ISSN: 2162-4011